title: TGFbeta and PTHrP control chondrocyte proliferation by activating cyclin D1 expression.
abstract: Exact coordination of growth plate chondrocyte proliferation is necessary for normal endochondral bone development and growth. Here we show that PTHrP and TGFbeta control chondrocyte cell cycle progression and proliferation by stimulating signaling pathways that activate transcription from the cyclin D1 promoter. The TGFbeta pathway activates the transcription factor ATF-2, whereas PTHrP uses the related transcription factor CREB, to stimulate cyclin D1 promoter activity via the CRE promoter element. Inhibition of cyclin D1 expression with antisense oligonucleotides causes a delay in progression of chondrocytes through the G1 phase of the cell cycle, reduced E2F activity, and decreased proliferation. Growth plates from cyclin D1-deficient mice display a smaller zone of proliferating chondrocytes, confirming the requirement for cyclin D1 in chondrocyte proliferation in vivo. These data identify the cyclin D1 gene as an essential component of chondrocyte proliferation as well as a fundamental target gene of TGFbeta and PTHrP during skeletal growth.
authors.affiliation: Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta, Canada T2N 4N1.
authors.forename: F
authors.initials: F
authors.lastname: Beier
authors.forename: Z
authors.initials: Z
authors.lastname: Ali
authors.forename: D
authors.initials: D
authors.lastname: Mok
authors.forename: A C
authors.initials: AC
authors.lastname: Taylor
authors.forename: T
authors.initials: T
authors.lastname: Leask
authors.forename: C
authors.initials: C
authors.lastname: Albanese
authors.forename: R G
authors.initials: RG
authors.lastname: Pestell
authors.forename: P
authors.initials: P
authors.lastname: LuValle
mesh_terms: D051698:Activating Transcription Factor 2; D000818:Animals; D002455:Cell Division / Q000187:drug effects; D019902:Chondrocytes / Q000166:cytology* / Q000187:drug effects* / Q000378:metabolism; D017362:Cyclic AMP Response Element-Binding Protein / Q000378:metabolism; D019938:Cyclin D1 / Q000235:genetics / Q000378:metabolism*; D005434:Flow Cytometry; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D008934:Mitogens / Q000494:pharmacology; D044162:Parathyroid Hormone-Related Protein; D011506:Proteins / Q000494:pharmacology*; D014157:Transcription Factors / Q000172:deficiency / Q000378:metabolism; D014158:Transcription, Genetic / Q000187:drug effects; D014162:Transfection; D016212:Transforming Growth Factor beta / Q000494:pharmacology*
chemical_list: C497105:ATF2 protein, human; D051698:Activating Transcription Factor 2; C497106:Atf2 protein, mouse; D017362:Cyclic AMP Response Element-Binding Protein; D008934:Mitogens; C470121:PTHLH protein, human; D044162:Parathyroid Hormone-Related Protein; D011506:Proteins; D014157:Transcription Factors; D016212:Transforming Growth Factor beta; D019938:Cyclin D1